SAMUELSON DOUG (Chief Financial Officer) received a stock award from KAIROS PHARMA, LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/26/2025ACC: 0001493152-25-025198
Officer· Chief Financial Officer
Since Sep 2024
+152.67K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
152.67K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+152.67K
Price / share
—
Trade value
—
% of position
108.8%
10/8/2025
140.37K→293.04K
Total
Net shares
+152.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 10/8/2025 | A · Award | +152.67K | — | — | 108.8% | 140.37K | 293.04K |
| Total | +152.67K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported